Your browser doesn't support javascript.
loading
Cardiovascular Outcomes with Finerenone According to Glycemic Status at Baseline and Prior Treatment with Newer Antidiabetics among Patients with Type 2 Diabetes Mellitus.
Patoulias, Dimitrios; Papadopoulos, Christodoulos; Karagiannis, Asterios; Vassilikos, Vassilios; Doumas, Michael.
Affiliation
  • Patoulias D; Second Propedeutic Department of Internal Medicine, Hippokration General Hospital,Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Papadopoulos C; Third Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Karagiannis A; Second Propedeutic Department of Internal Medicine, Hippokration General Hospital,Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Vassilikos V; Third Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Doumas M; Second Propedeutic Department of Internal Medicine, Hippokration General Hospital,Aristotle University of Thessaloniki, Thessaloniki, Greece.
Endocrinol Metab (Seoul) ; 37(1): 170-174, 2022 02.
Article in En | MEDLINE | ID: mdl-35144333

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Myocardial Infarction Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Endocrinol Metab (Seoul) Year: 2022 Document type: Article Affiliation country: Greece Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Myocardial Infarction Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Endocrinol Metab (Seoul) Year: 2022 Document type: Article Affiliation country: Greece Country of publication: